pre-update Archives

Blog

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies…

CertaraMay 10, 2024

Announcement

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research …

CertaraMay 10, 2024

Fact Sheet

Accelerate your drug discovery research with D360 and Design Hub

CertaraMay 10, 2024

Live Events

CERTAINTY – Japan

GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…

CertaraMay 7, 2024

Live Events

CERTAINTY – South Korea

GREATER CERTAINTY IN DRUG DEVELOPMENT Certainty by Certara offers exclusive access to industry leaders and clinical…

CertaraMay 7, 2024

Press Release

Certara Reports First Quarter 2024 Financial Result

Reiterates Full Year 2024 Financial Guidance PRINCETON, N.J.— May 7, 2024-- Certara, Inc. (Nasdaq: CERT), a…

CertaraMay 7, 2024

Guide

A Best Practice Guide to CDISC SDTM Mapping

CertaraMay 7, 2024

Publication

Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future

The article "Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future" by Karen Rowland…

CertaraMay 6, 2024

Publication

Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model

The rapid growth in the use of pediatric physiologically based pharmacokinetic (PBPK) models, particularly for…

CertaraMay 6, 2024

On-Demand Webinar

RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting

Meeting the escalating global demand for new medications requires expediting regulatory submission development. Documenting drug…

CertaraMay 3, 2024

pre-update

Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates

CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA

Accelerate your drug discovery research with D360 and Design Hub

CERTAINTY – Japan

CERTAINTY – South Korea

Certara Reports First Quarter 2024 Financial Result

A Best Practice Guide to CDISC SDTM Mapping

Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future

Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model

RAPS Sponsored Webcast: Regulatory & Tech Advances in Drug Safety Reporting

Newsletter sign up

Quick links

Solutions

Contact